Medicare Enrolled
Dr. Kambiz Shetabi, M.D.
Cardiovascular Disease · National City, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shetabi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shetabi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shetabi
Dr. Kambiz Shetabi is a cardiovascular disease specialist in National City, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Shetabi performed 1,984 Medicare services across 1,062 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shetabi received a total of $11,261 from 37 pharmaceutical and/or device companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shetabi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 49% volume in CA
$11,261 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,984
Medicare services
Top 49% in CA for cardiovascular disease
1,062
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~124 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
440 | $98 | $365 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
254 | $12 | $47 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
233 | $65 | $188 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
228 | $108 | $407 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $140 | $533 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
68 | $47 | $1,000 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
54 | $76 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $131 | $526 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
51 | $10 | $164 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
44 | $11 | $42 |
| Arterial puncture or catheterization, arm or leg Insertion of a needle or tube into an artery in the arm or leg. This procedure is used to access the arterial system for diagnostic or therapeutic purposes. |
43 | $41 | $1,744 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
42 | $106 | $358 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
37 | $46 | $172 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
32 | $176 | $659 |
| Cardiac catheterization | 29 | $181 | $843 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
27 | $62 | $232 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
27 | $18 | $64 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
27 | $12 | $42 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $34 | $126 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
25 | $220 | $823 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
24 | $21 | $78 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
22 | $782 | $2,918 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
21 | $20 | $76 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
18 | $74 | $263 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $255 | $1,044 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
16 | $174 | $651 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
16 | $170 | $643 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
12 | $396 | $1,678 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
11 | $18 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
18.6% medium
75.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,261
Total received (2018-2024)
Avg $1,609/year across 7 years
Top 25% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
226
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,988 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$272 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$872
2023
$1,035
2022
$1,495
2021
$2,048
2020
$434
2019
$2,349
2018
$3,027
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$281
Merck Sharp & Dohme LLC
$103
SCPHARMACEUTICALS INC.
$85
PFIZER INC.
$68
Kiniksa Pharmaceuticals International, plc
$46
iRhythm Technologies, Inc.
$45
Novartis Pharmaceuticals Corporation
$45
ABIOMED
$37
SANOFI-AVENTIS U.S. LLC
$27
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$25
Novo Nordisk Inc
$24
Medtronic, Inc.
$24
Abbott Laboratories
$22
Amgen Inc.
$21
E.R. Squibb & Sons, L.L.C.
$21
Top 3 companies account for 53.7% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$2,202
Abbott Laboratories
$1,685
Philips Electronics North America Corporation
$1,339
Edwards Lifesciences Corporation
$1,076
ABIOMED
$883
Medtronic, Inc.
$746
Janssen Pharmaceuticals, Inc
$466
BOSTON SCIENTIFIC CORPORATION
$383
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$318
Astellas Pharma US Inc
$314
Merck Sharp & Dohme LLC
$279
Boston Scientific Corporation
$193
Shockwave Medical, Inc
$125
Biosense Webster, Inc.
$114
Amarin Pharma Inc.
$112
PFIZER INC.
$85
SCPHARMACEUTICALS INC.
$85
Novartis Pharmaceuticals Corporation
$79
Novo Nordisk Inc
$66
CVRx, Inc.
$63
AstraZeneca Pharmaceuticals LP
$62
BIOTRONIK INC.
$61
Esperion Therapeutics, Inc.
$53
E.R. Squibb & Sons, L.L.C.
$50
Kiniksa Pharmaceuticals International, plc
$46
iRhythm Technologies, Inc.
$45
Amgen Inc.
$45
Cardiovascular Systems Inc.
$44
Merck Sharp & Dohme Corporation
$41
CARDIVA MEDICAL, INC.
$40
ATRICURE, INC.
$37
Tactile Systems Technology Inc
$32
SANOFI-AVENTIS U.S. LLC
$27
Kiniksa Pharmaceuticals, Ltd.
$20
Akcea Therapeutics, Inc.
$20
Chiesi USA, Inc.
$14
Actelion Pharmaceuticals US, Inc.
$10
Top 3 companies account for 46.4% of all-time payments
Associated products mentioned in payments ›
AMPLATZER Occluders · AVEIR · AZURE XT DR MRI SURESCAN · Arcalyst · Assurity Pacemaker · Astron; Pulsar; AstronPulsar · BRILINTA · Barostim Neo System · CARDIOMEMS · CONFIRM RX · CROME DR MRI SURESCAN · CardioMEMS HF System · Cardiva VASCADE 6/7F VCS · Carto 3 · ClosureFast · Confirm Rx · CoreValve Evolut · Corlanor · Diamondback Peripheral · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ensite Cardiac Mapping System · FARXIGA · FLEXITOUCH · FUROSCIX · Flexitouch Plus · GENERAL STENTS · GENERAL VASCULAR INTERVENTION · General - Therapies · HawkOne · IVUS Systems · Impella · JOT DX · KENGREAL · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · Micra · NEXLETOL · Orsiro Mission · Ozempic · PK Papyrus · QUADRA ASSURA · Quadra Allure MP RF CRT Pacemkr · Repatha · Resolute · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SYNERGY · Supera peripheral stent system · TEGSEDI · UPTRAVI · VERQUVO · Vascepa · Vascular Closure Device · Vascular Lithotripsy · WATCHMAN · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
210
Per 100K population
6.4
County median income
$102,285
Nearest hospital
PARADISE VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shetabi is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shetabi experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Shetabi performed 440 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shetabi receive payments from pharmaceutical companies?
Yes. Dr. Shetabi received a total of $11,261 from 37 companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shetabi's costs compare to other cardiologists in National City?
Dr. Shetabi's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shetabi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in National City
Browse cardiologists in National City ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology